Commodore Capital L.P., 10% Owner at Satsuma Pharmaceuticals, Inc. (STSA), bought 2,922 shares at $5.42 ($16K) on 2021-11-24, disclosed to the SEC on 2021-11-29.
Open-market purchase of $16k STSA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| VERA | BUY | 2023-06-22 | $13.6M | — | Filing → |
| ELVN | BUY | 2023-02-27 | $14K | — | Filing → |
| IMRA | BUY | 2023-02-23 | $284K | — | Filing → |